BIOINFOGATE’S OFF-X REACHES HALF MILLION SAFETY ALERTS
OFF-X has become the largest translational safety and toxicity intelligence portal for drugs and targets of pharmacological interest.
Jan 13 ,2020
BIOINFOGATE TO PRESENT AT THE CHEM-BIO INFORMATICS SOCIETY (CBI) ANNUAL MEETING (TOKYO, JAPAN, OCTOBER 22-24, 2019)
Bioinfogate has been invited to a speak at the Chem-Bio Informatics Society (CBI) Annual Meeting “”Towards Seamless Integration of Structural Biology and Information Science”～Dawn of the AI era in drug discovery～” which takes place in Tokyo, Oct. 22-24, 2019.
Oct 10 ,2019
BIOINFOGATE EXHIBITING AT THE SAFETY PHARMACOLOGY SOCIETY ANNUAL MEETING IN BARCELONA
Bioinfogate will be showcasing some of their recent developments at the Safety Pharmacology Society Annual Meeting in Barcelona, September 23-26, 2019.
Sep 20 ,2019
RESEARCH INSTITUTES OF SWEDEN (RISE) INITIATES SUBSCRIPTION TO BIOINFOGATE OFF-X
Bioinfogate announced today the signing of a licensing agreement with RISE to access Bioinfogate’s translational safety intelligence portal, OFF-X.
Jun 20 ,2019
VHIO AND BIOINFOGATE PARTNER TO ENHANCE SAFETY ASSESSMENT
Announced today, the Vall d'Hebron Institute of Oncology - Bioinfogate collaboration will validate the utility of the OFF-X translational safety intelligence portal in the design of novel clinical trials, including first-in-human studies.
Jun 17 ,2019
BIOINFOGATE EXHIBITING AT WORLD PHARMA WEEK IN BOSTON, MA (JUNE 17-20, 2019)
Bioinfogate will be showcasing some of their recent developments at World Pharma Week in Boston, MA, June 17-20 2019.
Jun 14 ,2019
FDA AND BIOINFOGATE AGREE TO EXTEND THE MATERIAL TRANSFER AGREEMENT (MTA) TO ACCESS THE OFF-X TRANSLATIONAL SAFETY INTELLIGENCE PORTAL
The agreement aims to evaluate new approaches to enhance safety assessments of human pharmaceuticals and their associated molecular targets, supporting the FDA’s mission of protecting public health.
May 21 ,2019
NEW ALLIANCE BETWEEN CLARIVATE ANALYTICS AND BIOINFOGATE TO DELIVER SAFETY & TOXICITY INTELLIGENCE TO PHARMA AND HEALTHCARE RESEARCHERS AND DECISION MAKERS
Bioinfogate will cross-link the OFF-X translational safety intelligence portal with the Cortellis suite of solutions from Clarivate Analytics to enable enhanced insights for targets and drugs of interest
Feb 28 ,2019